Research & Clinical Trials
Study Combines PD-1 and CAR-T Immunotherapy to Treat Mesothelioma
- by Suzanne Dixon
- Research & Clinical Trials
- Jun 13, 2019
At the 2019 American Society of Clinical Oncology annual meeting, Dr. Prasad Adusumilli from Memorial Sloan Kettering Cancer Center shared exciting new results from his study on combination immunotherapy…
Read More
Study Finds Modest Reality of Immunotherapy for Cancer
- by Tim Povtak
- Research & Clinical Trials
- Jun 6, 2019
Less than 13% of cancer patients who receive checkpoint inhibitor drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) actually benefit from the much-heralded form of immunotherapy, new research shows.
Read More
Quality of Life Still Good with HIPEC Surgery for Peritoneal Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- May 22, 2019
Surgical oncologist Dr. Edward Levine was not surprised by the encouraging results of the recent study measuring quality-of-life issues following aggressive treatment for patients with peritoneal mesothelioma. He has…
Read More
Mesothelioma Clinical Trial Exploring Family Predisposition
- by Tim Povtak
- Research & Clinical Trials
- May 20, 2019
The National Cancer Institute has opened a clinical trial using mesothelioma patients and their family members to explore predisposition to the cancer and potential solutions to…
Read More
Latest T-Cell Study Opens for Mesothelioma Patients
- by Tim Povtak
- Research & Clinical Trials
- May 16, 2019
Sarah Cannon Research Institute in Nashville, Tennessee, and MD Anderson Cancer Center in Houston have opened a much-anticipated clinical trial involving a novel T-cell therapy for patients with mesothelioma.
Read More
New Radiotherapy Can Double Two-Year Survival for Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- May 14, 2019
A novel radiotherapy regimen can double the chances of surviving two or more years with pleural mesothelioma, according to Dr. Marco Trovo at University Hospital of Udine in…
Read More
Study: Elderly Mesothelioma Patients Denied Valuable Survival Time
- by Tim Povtak
- Research & Clinical Trials
- May 13, 2019
Almost two-thirds of the elderly patients being diagnosed with mesothelioma are dying without receiving any cancer-related treatment that could significantly extend survival. Median survival is just 4.1 months,…
Read More
Novel Imaging May Make Peritoneal Mesothelioma Surgery More Effective
- by Tim Povtak
- Research & Clinical Trials
- May 6, 2019
Dr. James Cusack at Massachusetts General Hospital has begun using a novel imaging system for patients with peritoneal mesothelioma that could better identify tumor cells during surgery, reducing the…
Read More
NIOSH Asking for National Mesothelioma Registry Input
- by Tim Povtak
- Research & Clinical Trials
- May 1, 2019
The National Institute for Occupational Safety and Health has begun soliciting public input on the feasibility of establishing a mesothelioma registry. NIOSH is encouraging doctors, nurses, patients, families…
Read More
Optimism High for Mesothelioma Immunotherapy Clinical Trial in Europe
- by Tim Povtak
- Research & Clinical Trials
- Apr 23, 2019
A novel clinical trial aiming to train the immune system to recognize and attack pleural mesothelioma tumor cells has opened with considerable optimism across five European countries. The randomized…
Read More
